|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/47 | |||
| C07K 16/06 | |||
| C12N 9/26 | |||
| A61P 37/00 |
| (11) | Number of the document | 2271363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09721669.1 |
| Date of filing the European patent application | 2009-03-16 | |
| (97) | Date of publication of the European application | 2011-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/001670 |
| Date | 2009-03-16 |
| (87) | Number | WO 2009/117085 |
| Date | 2009-09-24 |
| (30) | Number | Date | Country code |
| 69841 P | 2008-03-17 | US |
| (72) |
SCHIFF, Richard, US
LEIBL, Heinz, AT
FROST, Gregory, I., US
|
| (73) |
Baxalta GmbH,
Thurgauerstrasse 130, 8152 Glattpark, Opfikon,
CH
Baxalta Incorporated, 1200 Lakeside Drive, Bannockburn, IL 60015, US |
| (54) | COMBINATIONS AND METHODS FOR SUBCUTANEOUS ADMINISTRATION OF IMMUNE GLOBULIN AND HYALURONIDASE |
| COMBINATIONS AND METHODS FOR SUBCUTANEOUS ADMINISTRATION OF IMMUNE GLOBULIN AND HYALURONIDASE |